, Volume 31, Issue 8, pp 567–575

The skin in diabetes mellitus

  • M. J. D. Goodfield
  • L. G. Millard


The skin is one of the major organ systems involved in diabetes. Certain changes occur inevitably in this disease, and are undoubtedly the cause of many of the skin disorders seen in patients with diabetes. Other skin disorders are related to common disease processes, and still others are simply unexplained statistical observation.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Huntley AC (1982) Diabetes and the skin. J Am Acad Dermatol 7: 427–455Google Scholar
  2. 2.
    Braverman IM, Yen AK (1984) Ultrastructural abnormalities of the microvasculature and elastic fibres in the skin of juvenile diabetics. J Invest Dermatol 82: 270–274Google Scholar
  3. 3.
    Cox NH, McCruden D, McQueen A, Jones SK, Ong-Tone L, Finlay AY, Frier BM (1987) Histological findings in clinically normal skin of patients with insulin-dependent diabetes. Clin Exp Dermatol 12: 250–255Google Scholar
  4. 4.
    Buckingham BA, Uitto J, Sandborg C, Keens T, Kaufman F, Landing B (1981) Scleroderma like syndrome and non-enzymatic glycosylation of collagen in children with poorly controlled insulin-dependent diabetes. Paediatr Res 15: 626 (Abstract)Google Scholar
  5. 5.
    Monnier VM, Kohn RR, Cerami A (1984) Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci USA 81: 583–587Google Scholar
  6. 6.
    Brownlee M, Vlassara H, Cerami A (1984) Non-enzymatic glycosylation and the pathogenesis of diabetic complications. Ann Int Med 101: 527–537Google Scholar
  7. 7.
    Kennedy L, Baynes JW (1984) Non-enzymatic glycoylation and the chronic complications of diabetes. An overview. Diabetologia 26: 93–98Google Scholar
  8. 8.
    Thomas D, Delbridge L, Morris D, Howell M (1984) Cyclohexanone extraction: an improvement on the thiobarbituric acid method for the determination of non-enzymatic glycosylation of epidermal keratin and hair. Scand J Lab Clin Invest 44: 457–459Google Scholar
  9. 9.
    Seibold JR, Uitto J, Dorwart BB, Prockop DJ (1985) Collagen synthesis and collagenase activity in dermal fibroblasts from patients with diabetes and digital sclerosis. J Lab Clin Med 105: 664–667Google Scholar
  10. 10.
    Hanna W, Friesen D, Bombardier C, Gladman D, Hanna A (1987) Pathologic features of diabetaic thick skin. J Am Acad Dermatol 16: 546–553Google Scholar
  11. 11.
    Caulfield JB (1965) Comparison of the ultrastracture of normal and diabetic elastic tissue. Fed Proc 24: 433Google Scholar
  12. 12.
    Dowd PM, Gaywood IC, Kurtz AB, Shipley ME (1986) Diabetic Sclerodactyly. Br J Dermatol 116: 21 (Abstract)Google Scholar
  13. 13.
    Monnier VM, Vishwanath V, Frank KE, Elmets CA, Dauchot P, Kohn RR (1986) Relationship between complications of Type I diabetes mellitus and collagen linked fluorescence. N Engl J Med 314: 403–407Google Scholar
  14. 14.
    Leiberman LS, Rosenbloom AL, Riley WJ, Silverstein JH (1980) Reduced skin thickness with pump administration of insulin. N Engl J Med 303: 940–941Google Scholar
  15. 15.
    Lister DM, Graham-Brown RAC, Burden AC (1986) Resolution of Diabetic cheiroarthropathy. Br Med J 293: 1537Google Scholar
  16. 16.
    Ditzel J, Rooth G (1955) the micro-angiopathy in diabetes mellitus. A concept regarding its mechanism of origin. Diabetes 4: 474–475Google Scholar
  17. 17.
    Braverman IM, Sibley J, Yen AK (1986) A study of the veil cells around normal, diabetic and aged cutaneous micro-vessels. J Invest Dermatol 86: 57–62Google Scholar
  18. 18.
    Vracko R (1970) Skeletal muscle capillaries in diabetics. Circulation 41: 271–283Google Scholar
  19. 19.
    Rayman G, Hassan AAK, Tooke JE (1986) Blood flow in the skin of the foot related to posture in diabetes mellitus. Br Med J 293: 87–90Google Scholar
  20. 20.
    Chalmers RJG, Ead RD, Beck MH, Dewis P, Anderson DC (1983) Acne Vulgaris and hidradenitis suppurativa as presenting features of acromegaly. Br Med J 287: 1346–1347Google Scholar
  21. 21.
    Martin MM (1953) Involvement of autonomie nerve fibres in diabetic neuropathy. Lancet 264: 560–565Google Scholar
  22. 22.
    Watkins PJ (1973) Facial sweating after food: a new sign of diabetic neuropathy. Br Med J 1: 583–587Google Scholar
  23. 23.
    Rosenbloom AL, Silverstein JH, Lezotte DC, Richardson K, McCallum M (1981) Limited joint mobility in childhood diabetes mellitus indicates increased risk of microvascular disease. N Engl J Med 305: 191–194Google Scholar
  24. 24.
    Burton JL (1982) Thick skin and stiff joints in insulin dependent diabetes mellitus. Br J Dermatol 106: 369–371Google Scholar
  25. 25.
    Larkin JG, Frier BM (1986) Limited joint mobility and Dupuytren's contracture in diabetic, hypertensive and normal populations. Br Med J 292: 1494Google Scholar
  26. 26.
    Grgic A, Rosenbloom AL, Webber FT, Giordano B, Malone GI, Shuster JJ (1976) Joint contracture — common manifestations of childhood diabetes mellitus. J Paediatr 88: 584–588Google Scholar
  27. 27.
    Lyons TJ, Kennedy L (1985) Non-enzymatic glycosylation of skin collagen in patients with Type 1 (insulin-dependent) diabetes mellitus and limited joint mobility. Diabetologia 28: 2–5Google Scholar
  28. 28.
    Buckingham BA, Uitto J, Sandborg C, Keens T, Kaufman F, Landing B (1984) Scleroderma-like changes in insulin dependent diabetes mellitus: clinical and biochemical studies. Diabetes Care 7: 163–169Google Scholar
  29. 29.
    Fleischmajer R, Faludi G, Krol S (1970) Scleredema and diabetes mellitus. Arch Dermatol 101: 21–26Google Scholar
  30. 30.
    Fleischmajer R, Perlish JS (1972) Glycosaminoglycans in scleroderma and scleredema. J Invest Dermatol 58: 129–132Google Scholar
  31. 31.
    Cole GW, Headley J, Skowsky R (1983) Scleredema diabeticorum: a common and distinct cutaneous manifestation of diabetes mellitus. Diabetes Care 6: 189–192Google Scholar
  32. 32.
    Holubar K, Mach KW (1967) Scleredema (Buschke). Acta Derm Venereol (Stockh) 47: 102–110Google Scholar
  33. 33.
    Cantwell AR, Kelso DW (1980) Histological observation of pleomorphic Corynebacterium-like micro-organisms in diabetic scleredema adultoram. Cutis 26: 573–583Google Scholar
  34. 34.
    Aberer E, Stankek G, Ertl M, Neumann R (1987) Evidence for spirochaetal origin of circumscribed scleroderma. Acta Derm Venereol 67: 225–232Google Scholar
  35. 35.
    Rocca F, Peraya E (1963) Phlyctenar lesions in the feet of diabetic patients. Diabetes 12: 220–222Google Scholar
  36. 36.
    Cantwell AR, Martz W (1967) Idiopathic Bullae in diabetes mellitus: bullosis diabeticoram. Arch Dermatol 96: 42–44Google Scholar
  37. 37.
    Kurwa A, Roberts P, Whitehead R (1971) Concurrence of bullous and atrophie skin lesions in diabetes mellitus. Arch Dermatol 103: 670–675Google Scholar
  38. 38.
    Bernstein JE, Medenica M, Soltani K (1979) Bullous eruption of diabetes mellitus. Arch Dermatol 115: 324–326Google Scholar
  39. 39.
    Toonstra J (1985) Bullosis Diabeticorom. J Am Acad Dermatol 13: 799–805Google Scholar
  40. 40.
    Kerl H, Kresbach H (1974) Zu einigen aspecten der “Bullosis diabeticoram”. Hautarzt 25: 60–65Google Scholar
  41. 41.
    James WD, Odom RB, Goette DK (1980) Bullous eruption of diabetes mellitus: a case with positive immunofluorescence microscopy findings. Arch Dermatol 116: 1191–1192Google Scholar
  42. 42.
    Goodfield MJD, Jeffcoate WJ, Harvey L, Millard LG (1986) Bullosis diabeticorum. J Am Acad Dermatol 15: 1192–1194Google Scholar
  43. 43.
    Haroon TS (1974) Diabetes and the skin — a review. Scott Med J 19: 257–267Google Scholar
  44. 44.
    Dicken CH, Carrington SG, Winkelman RK (1969) Generalised granuloma annulare. Arch Derm 99: 556–563Google Scholar
  45. 45.
    Romaine R, Rudner EJ, Altaian J (1968) Papular granuloma annulare and diabetes mellitus: report of cases. Arch Dermatol 98: 152–154Google Scholar
  46. 46.
    Haim S, Friedman-Birnbaum R, Shafrir A (1970) Generalised granuloma annulare: relationship to diabetes mellitus as revealed in 8 cases. Br J Dermatol 83: 302–305Google Scholar
  47. 47.
    Cunliffe WJ (1986) Necrobiotic disorders. In: Rook A, Wilkinson DS, Ebling FJG, Champion RH, Burton JL (eds) Textbook of Dermatology. Blackwell, Oxford, pp 1687–1698Google Scholar
  48. 48.
    Muhlbauer JE (1980) Granuloma annulare. J Am Acad Dermatol 3: 217–230Google Scholar
  49. 49.
    Burton JL (1977) Granuloma annulare, rheumatoid nodules and necrobiosis lipoidica. Br J Dermatol 97 [Suppl 15]: 52–54Google Scholar
  50. 50.
    Rudge S, Baron FM, Drury P (1982) Lack of association between rheumatoid arthritis and Type I (insulin dependent) diabetes. J Rheumatol 9: 343–344 (Letter)Google Scholar
  51. 51.
    Mobacken H, Gisslen H, Johannisson G (1970) Granuloma annulare: cortisone-glucose tolerance test in a non-diabetic group. Acta Derm Venereol 50: 440–444Google Scholar
  52. 52.
    Rhodes EL, Hill DM, Ames AC, Tourle CA, Taylor CG (1966) Granuloma annulare: Prednisone glycosuria tests in a non-diabetic group. Br J Dermatol 78: 532–535Google Scholar
  53. 53.
    Koh MS, Majewski BBJ, Barter S, Chilvers C, Rhodes EL (1983) Serum B-glucuronidase activity in human diabetes mellitus, granuloma annulare and necrobiosis lipoidica. Clin Exp Dermatol 8: 299–304Google Scholar
  54. 54.
    Muhlemann MF, Williams DRR (1984) Localised granuloma annulare is associated with insulin-dependent diabetes mellitus. Br Med J 111: 325–329Google Scholar
  55. 55.
    Muller SA, Winkelman RK (1966) Necrobiosis lipoidica diabeticorum: a clinical and pathological investigation of 117 cases. Arch Dermatol 93: 272–281Google Scholar
  56. 56.
    Smith JG Jr (1956) Necrobiosis lipoidica: a disease of changing concepts. Arch Dermatol 74: 280–285Google Scholar
  57. 57.
    Ackerman AB (1978) Histological diagnosis of inflammatory skin diseases. A method by pattern analysis. Lea & Febiger, Philadelphia, pp 424–431Google Scholar
  58. 58.
    Bauer MF, Hirsch P, Bullock WK, Abul-Haj SK (1964) Necrobiosis lipoidica. A cutaneous manifestation of diabetic microangiopathy. Arch Dermatol 90: 558–564Google Scholar
  59. 59.
    Tkach JR (1982) Platelet-inhibition therapy of ulcerated necrobiosis lipoidica diabeticorum. Dermatol Allergy 5: 9–12Google Scholar
  60. 60.
    Eldor S, Diaz EG, Naparstek E (1978) Treatment of diabetic necrobiosis with aspirin and dipyridamole. N Engl J Med 298: 1033Google Scholar
  61. 61.
    Statham B, Finlay AY, Marks R (1981) A randomized double blind comparison of aspirin dipyridamole combination versus a placebo in the treatment of necrobiosis lipoidica. Acta Derm Venereol 61: 270–271Google Scholar
  62. 62.
    Dahl MV, Ullman S, Fisher I (1976) Direct immunofluorescence of granuloma annulare and necrobiosis lipoidica. Clin Res 24: 95aGoogle Scholar
  63. 63.
    Oikarinen A, Mortenkunen M, Kallioinen M, Savolainen E (1987) Necrobiosis lipoidica: ultrastractural and biochemical demonstration of a collagen defect. J Invest Dermatol 88: 227–232Google Scholar
  64. 64.
    Jilek M, Jezkova Z (1970) Immunological processes in the pathogenesis of necrobiosis lipoidica diabeticorum. Cesk Dermatol 45: 1–5Google Scholar
  65. 65.
    Gupta AK, Anderson TF (1987) Psoralen photochemotherapy. J Am Acad Dermatol 17: 703–734Google Scholar
  66. 66.
    Cunliffe WJ (1986) Necrobiotic disorders. In: Rook A, Wilkinson DS, Ebling FJG, Champion RH, Burton JL (eds) Textbook of dermatology. Blackwell, Oxford, pp 1687–1698Google Scholar
  67. 67.
    Muller SE (1966) Dermatological disorders associated with diabetes mellitus. Mayo Clin Proc 41: 689–703Google Scholar
  68. 68.
    Kahn CR, Flier JS, Bar RS (1976) The syndromes of insulin resistance and acanthosis nigricans: insulin receptor disoreders in man. N Engl J Med 294: 739–745Google Scholar
  69. 69.
    Flier JS (1983) Insulin receptors and insulin resistance. Ann Rev Med 34: 145–150Google Scholar
  70. 70.
    Kahn CR, Baird KL, Flier JS (1981) Insulin receptors, receptor antibodies and the mechanism of insulin action. Recent Prog Horm Res 37: 477–538Google Scholar
  71. 71.
    Flier JS (1985) Metabolic importance of acanthosis nigricans. Arch Dermatol 121: 193–194Google Scholar
  72. 72.
    Blundell TL, Bedarkian S, Humbel RE (1983) Tertiary structures, receptor binding, and antigenicity of insulin-like growth factors. Fed Proc 42: 2592–2597Google Scholar
  73. 73.
    Burghen GA, Givens JR, Kitabchi AE (1980) Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metabol 50: 113–116Google Scholar
  74. 74.
    Shuttleworth D, Weawind GP, Braham-Brown RAC (1987) Acanthosis nigricans and diabetes mellitus in a patient with Klinefelter's syndrome: a reaction to methyltestosterone. Clin Exp Dermatol 12: 288–290Google Scholar
  75. 75.
    Waisman M (1957) Cutaneous papillomas of the neck: papillomatous seborrheoic keratoses. South Med J 50: 725–731Google Scholar
  76. 76.
    Margolis J, Margolis LS (1976) Skin tags — a frequent sign in diabetes mellitus. N Engl J Med 294: 1184Google Scholar
  77. 77.
    Alberti KGMM, Hockaday TDR (1986) Diabetes mellitus. In: Weatherall DJ, Ledingham JGG, Warrell DA (eds) Oxford Textbook of Medicine. University Press, Oxford, pp 9.5–9.49Google Scholar
  78. 78.
    Young RJ, Steel JM, Frier BM, Duncan LPJ (1981) Insulin injection sites in diabetes — a neglected area? Br Med J 283: 349Google Scholar
  79. 79.
    Renold AE, Marble A, Fawcett DW (1950) Action of insulin on deposition of glycogen and storage of fat in subcutaneous tissue. Endocrinology 46: 55–61Google Scholar
  80. 80.
    Mier A, Weerakoon J, Dandona P (1982) Bilateral abdominal lipohypertrophy after continuous subcutaneous infusion of insulin. Br Med J 285: 1539Google Scholar
  81. 81.
    Drell DW, Notkins AL (1987) Multiple immunological abnormalities in patients with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30: 132–144Google Scholar
  82. 82.
    Bleehen SS, Ebling FJG (1986) Disorders of skin colour. In: Rook A, Wilkinson DS, Ebling FJG, Champion RH, Burton JL (eds) Textbook of Dermatology. Blackwell, Oxford, pp 1543–1604Google Scholar
  83. 83.
    Dawber RPR (1968) Vitiligo in maturity onset diabetes mellitus. Br J Dermatol 80: 275–278Google Scholar
  84. 84.
    Macaron C, Winter RJ, Traisman HS, Kahan BD, Lassar AE, Green OC (1977) Vitiligo and juvenile diabetes mellitus. Arch Dermatol 113: 1515–1517Google Scholar
  85. 85.
    Meyrick Thomas RH, Ridley CM, Mcgibbon DH, Black MM (1988) Lichen sclerosus et atrophicus and auto-immunity — a study of 350 women. Br J Dermatol 118: 41–46Google Scholar
  86. 86.
    Lever WF (1953) Pemphigus. Medicine 32: 1–123Google Scholar
  87. 87.
    Jordan RE, Beutner EH, Witebsky E, Blumenthal G, Hale WL, Lever WF (1967) Basement membrane zone antibodies in bullous pemphigoid. JAMA 200: 751–756Google Scholar
  88. 88.
    Stanley JR (1985) A specific antigen-antibody interaction triggers the cellular pathophysiology of bullous pemphigoid. Br J Dermatol 113 [Suppl 28]: 67–73Google Scholar
  89. 89.
    Ahmed AR, Maize JC, Brovost TT (1977) Bullous pemphigoid: clinical and immunological follow-up after successful therapy. Arch Dermatol 113: 1043–1046Google Scholar
  90. 90.
    Chuang T, Korkij W, Soltani K, Clayman J, Cook J (1984) Increased ferquency of diabetes mellitus in patients with bullous pemphigoid: a case control study. J Am acad Dermatol 11: 1099–1102Google Scholar
  91. 91.
    Jolly M (1972) Lichen planus and its association with diabetes mellitus. Med J Aust 59: 990–992Google Scholar
  92. 92.
    Halevy S, Feurman EJ (1979) Abnormal glucose tolerance associated with lichen planus. Acta Derm Venereol 59: 167–170Google Scholar
  93. 93.
    Black MM (1986) Lichen planus and lichenoid eruptions. In: Rook A, Wilkinson DS, Ebling FJG, Champion RH, Burton JL (eds) Textbook of Dermatology. Blackwell, Oxford, pp 1665–1685Google Scholar
  94. 94.
    Thomas ED (1975) Graft-versus Host Disease. N Engl J Med 292: 895–899Google Scholar
  95. 95.
    Shuttleworth D, Graham-Brown RAC, Campbell AC (1986) The autoimmune background in lichen planus. Br J Dermatol 115: 199–203Google Scholar
  96. 96.
    Daggett P, Mustaffa BE, Nabarro JDN (1977) Improvements in skin reactions to insulin, produced by a highly purified preparation. Br J Dermatol 96: 439–443Google Scholar
  97. 97.
    Feinglos MM, Jegasothy BV (1979) “Insulin” allergy due to zinc. Lancet I: 122–124Google Scholar
  98. 98.
    Bloom SR, Barnes AJ, Adrian TE, Polak JM (1979) Auto-immunity in diabetes induced by hormonal contaminants of insulin. Lancet I: 14–17Google Scholar
  99. 99.
    Galloway JA, Bressler R (1978) Insulin therapy in diabetes. Med Clin North Am 62: 663–671Google Scholar
  100. 100.
    Holdaway IM, Wilson JD (1984) Cutaneous insulin allergy responsive to oral desensitisation and aspirin. Br Med J 289: 1565–1566Google Scholar
  101. 101.
    Reeves WG, Allen BR, Tattersall RB (1980) Insulin induced lipo-atrophy: evidence for an immune pathogenesis. Br Med J 280: 1500–1503Google Scholar
  102. 102.
    Burton JL, Cunliffe WJ (1986) The subcutaneous fat. In: Rook A, Wilkinson DS, Ebling FJG, Champion RH, Burton JL (eds) Textbook of Dermatology. Blackwell, Oxford, pp 1859–1879Google Scholar
  103. 103.
    Winkelman RK (1983) Panniculitis in connective tissue disease. Arch Dermatol 119: 336–344Google Scholar
  104. 104.
    Tenscher A (1974) Treatment of insulin lipo-atrophy with monocomponent insulin. Diabetologia 10: 211–214Google Scholar
  105. 105.
    Jones GR, Statham B, Owen DR, Jones MK, Hayes TM (1981) Lipo-atrophy and monocomponent porcine insulin. Br Med J 282: 190Google Scholar
  106. 106.
    Wilson RM (1986) Neutrophil function in diabetes. Diabetic Med 3: 509–512Google Scholar
  107. 107.
    MacCuish AC, Jordan J, Campbell CJ, Duncan LPJ, Irvine WJ (1974) Cell mediated immunity to human pancreas in diabetes mellitus. Diabetes 23: 693–697Google Scholar

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • M. J. D. Goodfield
    • 1
  • L. G. Millard
    • 2
  1. 1.Department of DermatologyLeeds General InfirmaryUK
  2. 2.Department of DermatologyUniversity HospitalNottinghamUK

Personalised recommendations